VivaZome and Toolgen extend collaboration based on successful proof-of-concept

Under the pilot study, ToolGen undertook a knock-down gene editing using its CRISPR/Cas9 technology, with the gene and the cell specified by VivaZome. The gene editing was successfully accomplished and exosome production by the edited cells was maintained at high levels.
The nest aim to create a gene-edited cell that could be used in VivaZome’s exosome manufacturing process.

Read the full media release here